Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients

M.B. Toft-Nielsen; S. Madsbad; J.J. Holst

Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients

M.B. Toft-Nielsen, S. Madsbad, J.J. Holst

Endocrinology and Metabolism

298 Citations (Scopus)

Original language	English
Journal	Diabetes Care
Issue number	22
Pages (from-to)	1137-1143
ISSN	0149-5992
Publication status	Published - 1999

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{fd94a4e074c811dbbee902004c4f4f50,

title = "Continuous subcutaneous infusion of Glucagon-like Peptide-1 (GLP-1) lowers plasma glucose and reduces appetite in type II diabetic patients",

author = "M.B. Toft-Nielsen and S. Madsbad and J.J. Holst",

year = "1999",

language = "English",

pages = "1137--1143",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association",

number = "22",

}